Literature DB >> 29237831

Maintenance of AP-2-Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.

Blake Schouest1, Andrea M Weiler2, Sanath Kumar Janaka3, Tereance A Myers1, Arpita Das1, Sarah C Wilder1, Jessica Furlott2, Melody Baddoo4, Erik K Flemington4,5, Eva G Rakasz2, David T Evans2,3, Thomas C Friedrich2,6, Nicholas J Maness7,8.   

Abstract

Nef-specific CD8+ T lymphocytes (CD8TL) are linked to extraordinary control of primate lentiviral replication, but the mechanisms underlying their efficacy remain largely unknown. The immunodominant, Mamu-B*017:01+-restricted Nef195-203MW9 epitope in SIVmac239 partially overlaps a sorting motif important for interactions with host AP-2 proteins and, hence, downmodulation of several host proteins, including Tetherin (CD317/BST-2), CD28, CD4, SERINC3, and SERINC5. We reasoned that CD8TL-driven evolution in this epitope might compromise Nef's ability to modulate these important molecules. Here, we used deep sequencing of SIV from nine B*017:01+ macaques throughout infection with SIVmac239 to characterize the patterns of viral escape in this epitope and then assayed the impacts of these variants on Nef-mediated modulation of multiple host molecules. Acute variation in multiple Nef195-203MW9 residues significantly compromised Nef's ability to downregulate surface Tetherin, CD4, and CD28 and reduced its ability to prevent SERINC5-mediated reduction in viral infectivity but did not impact downregulation of CD3 or major histocompatibility complex class I, suggesting the selective disruption of immunomodulatory pathways involving Nef AP-2 interactions. Together, our data illuminate a pattern of viral escape dictated by a selective balance to maintain AP-2-mediated downregulation while evading epitope-specific CD8TL responses. These data could shed light on mechanisms of both CD8TL-driven viral control generally and on Mamu-B*017:01-mediated viral control specifically.IMPORTANCE A rare subset of humans infected with HIV-1 and macaques infected with SIV can control the virus without aid of antiviral medications. A common feature of these individuals is the ability to mount unusually effective CD8 T lymphocyte responses against the virus. One of the most formidable aspects of HIV is its ability to evolve to evade immune responses, particularly CD8 T lymphocytes. We show that macaques that target a specific peptide in the SIV Nef protein are capable of better control of the virus and that, as the virus evolves to escape this response, it does so at a cost to specific functions performed by the Nef protein. Our results help show how the virus can be controlled by an immune response, which could help in designing effective vaccines.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  CD4; SERINC; Tetherin; evolution; major histocompatibility complex; simian immunodeficiency virus; viral escape

Mesh:

Substances:

Year:  2018        PMID: 29237831      PMCID: PMC5809740          DOI: 10.1128/JVI.01822-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  87 in total

1.  HIV-1 Nef impairs MHC class II antigen presentation and surface expression.

Authors:  P Stumptner-Cuvelette; S Morchoisne; M Dugast; S Le Gall; G Raposo; O Schwartz; P Benaroch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

2.  Structural requirements for interactions between leucine-sorting signals and clathrin-associated adaptor protein complex AP3.

Authors:  Dmitrii G Rodionov; Stefan Höning; Aleksandra Silye; Thomas L Kongsvik; Kurt von Figura; Oddmund Bakke
Journal:  J Biol Chem       Date:  2002-10-04       Impact factor: 5.157

3.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs.

Authors:  Ashutosh Chaudhry; Suman Ranjan Das; Amjad Hussain; Satyajit Mayor; Anna George; Vineeta Bal; Shahid Jameel; Satyajit Rath
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

5.  The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild.

Authors:  Anke Heigele; Dorota Kmiec; Kerstin Regensburger; Simon Langer; Lukas Peiffer; Christina M Stürzel; Daniel Sauter; Martine Peeters; Massimo Pizzato; Gerald H Learn; Beatrice H Hahn; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2016-09-14       Impact factor: 21.023

6.  Down-modulation of CD8αβ is a fundamental activity of primate lentiviral Nef proteins.

Authors:  Anke Heigele; Michael Schindler; Clement W Gnanadurai; Jolie A Leonard; Kathleen L Collins; Frank Kirchhoff
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

7.  The role of upstream U3 sequences in the pathogenesis of simian immunodeficiency virus-induced AIDS in rhesus monkeys.

Authors:  P O Ilyinskii; M D Daniel; M A Simon; A A Lackner; R C Desrosiers
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Specific CD8+ T cell responses correlate with control of simian immunodeficiency virus replication in Mauritian cynomolgus macaques.

Authors:  Melisa L Budde; Justin M Greene; Emily N Chin; Adam J Ericsen; Matthew Scarlotta; Brian T Cain; Ngoc H Pham; Ericka A Becker; Max Harris; Jason T Weinfurter; Shelby L O'Connor; Michael Piatak; Jeffrey D Lifson; Emma Gostick; David A Price; Thomas C Friedrich; David H O'Connor
Journal:  J Virol       Date:  2012-05-09       Impact factor: 5.103

9.  Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors.

Authors:  Maria Salgado; Timothy P Brennan; Karen A O'Connell; Justin R Bailey; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  Retrovirology       Date:  2010-11-08       Impact factor: 4.602

10.  Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.

Authors:  Paul A Goepfert; Wendy Lumm; Paul Farmer; Philippa Matthews; Andrew Prendergast; Jonathan M Carlson; Cynthia A Derdeyn; Jianming Tang; Richard A Kaslow; Anju Bansal; Karina Yusim; David Heckerman; Joseph Mulenga; Susan Allen; Philip J R Goulder; Eric Hunter
Journal:  J Exp Med       Date:  2008-04-21       Impact factor: 14.307

View more
  6 in total

1.  Structural Basis for Tetherin Antagonism as a Barrier to Zoonotic Lentiviral Transmission.

Authors:  Cosmo Z Buffalo; Christina M Stürzel; Elena Heusinger; Dorota Kmiec; Frank Kirchhoff; James H Hurley; Xuefeng Ren
Journal:  Cell Host Microbe       Date:  2019-08-22       Impact factor: 21.023

Review 2.  How HIV Nef Proteins Hijack Membrane Traffic To Promote Infection.

Authors:  Cosmo Z Buffalo; Yuichiro Iwamoto; James H Hurley; Xuefeng Ren
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

3.  Substitutions in Nef That Uncouple Tetherin and SERINC5 Antagonism Impair Simian Immunodeficiency Virus Replication in Primary Rhesus Macaque Lymphocytes.

Authors:  Sanath Kumar Janaka; Brian J Snow; Ryan T Behrens; David T Evans
Journal:  J Virol       Date:  2022-05-10       Impact factor: 6.549

4.  Selective Disruption of SERINC5 Antagonism by Nef Impairs SIV Replication in Primary CD4+ T Cells.

Authors:  Sanath Kumar Janaka; Alexandra V Palumbo; Aidin Tavakoli-Tameh; David T Evans
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

5.  Lovastatin Inhibits HIV-1-Induced MHC-I Downregulation by Targeting Nef-AP-1 Complex Formation: A New Strategy to Boost Immune Eradication of HIV-1 Infected Cells.

Authors:  Bingfeng Liu; Xu Zhang; Wanying Zhang; Liyang Wu; Shuliang Jing; Weiwei Liu; Baijin Xia; Fan Zou; Lijuan Lu; Xiancai Ma; Dalian He; Qifei Hu; Yiwen Zhang; Kai Deng; Weiping Cai; Xiaoping Tang; Tao Peng; Hui Zhang; Linghua Li
Journal:  Front Immunol       Date:  2019-09-10       Impact factor: 7.561

Review 6.  The Emerging Role of the Serine Incorporator Protein Family in Regulating Viral Infection.

Authors:  Shaofen Xu; Zhichao Zheng; Janak L Pathak; Haoyu Cheng; Ziliang Zhou; Yanping Chen; Qiuyu Wu; Lijing Wang; Mingtao Zeng; Lihong Wu
Journal:  Front Cell Dev Biol       Date:  2022-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.